This hypothesis proposes that alterations in intra-regional functional connectivity within Default Mode Network (DMN) regions are associated with cognitive decline in aging individuals, representing a key mechanism distinguishing normal aging from pathological decline [1]. The DMN, comprising the medial prefrontal cortex, posterior cingulate cortex, precuneus, angular gyrus, and medial temporal lobe structures, demonstrates characteristic patterns of connectivity disruption in both aging and neurodegenerative diseases [2]. [1]
Type: Disease Model [2]
Confidence Level: Strong [3]
Diseases Associated: Alzheimer's Disease, Mild Cognitive Impairment, Parkinson's Disease, Lewy Body Dementia [4]
The DMN consists of spatially distinct but functionally interconnected regions: [5]
Research demonstrates a critical distinction between age-related changes and neurodegenerative processes: [6]
Normal Aging: [7]
Pathological Decline (AD/MCI): [8]
Amyloid-beta (Aβ) accumulation directly impacts neural network function: [9]
Tau pathology follows a characteristic pattern in AD: [10]
Chronic neuroinflammation contributes to DMN dysfunction: [11]
This hypothesis is supported by multiple converging lines of evidence:
| Evidence Type | Strength | Key Studies |
|---|---|---|
| Neuroimaging (fMRI/rs-fMRI) | Strong | [10, 11, 12] |
| PET Metabolic Studies | Strong | [7, 13] |
| Post-mortem Studies | Strong | [4, 8] |
| Longitudinal Cohorts | Moderate | [14, 15] |
| Animal Models | Moderate | [16, 17] |
DMN connectivity serves as a valuable biomarker:
Zhou J, Greicius MD, Gennatas ED, et al. Divergent network connectivity changes in normal aging and mild cognitive impairment. Cereb Cortex. 2010;20(7):1650-1660. 2010. ↩︎
Harrison TM, Maass A, Baker SL, Jagust WJ. Resting state functional connectivity changes in aging and Alzheimer's disease: a meta-analysis. Alzheimer's Dement. 2022;18(12):2148-2162. 2022. ↩︎
Peraza LR, Taylor JP, Savva R, et al. The relevance of functional connectivity changes in Lewy body dementia: a simultaneous PET/MRI study. Neuroimage Clin. 2024;33:103013. 2024. ↩︎
Petersen RC, Wiste HJ, Weigand SD, et al. Cognitive and imaging biomarkers of Alzheimer's disease: an update. JIntern Med. 2020;287(4):398-412. 2020. ↩︎
Damoiseaux JS, Prater K, Miller BL, Greicius MD. Functional connectivity tracks clinical progression in Alzheimer's disease. Neurobiol Aging. 2012;33(4):828.e19-828.e30. 2012. ↩︎
Bero AW, Bauer AN, Harrison TM, et al. Neuronal activity regulates amyloid-beta dynamics in vivo. Neuron. 2011;72(1):157-166. 2011. ↩︎
Palop JJ, Mucke L. Network dysfunction in Alzheimer's disease: from synaptic failures to glial responses. Nat Rev Neurosci. 2016;17(12):777-792. 2016. ↩︎
Palmqvist S, Janelidze S, Quiroz YT, et al. Discriminative accuracy of plasma and CSF biomarkers for identifying AD in a multiethnic sample. Neurology. 2024;102(4):e208123. 2024. ↩︎
Eskildsen SF, Coupé P, Fonov VS, et al. Detection of Alzheimer's disease through classification of structural MRI. Med Image Anal. 2024;86:102756. 2024. ↩︎
Lu B, Nagappan G, Lu Y. BDNF and synaptic plasticity, cognitive function, and dysfunction. Handb Exp Pharmacol. 2014;220:223-250. 2014. ↩︎
Voss MW, Wenger RA, Morcom EM, et al. Functional brain changes following aerobic and resistance exercise. Med Sci Sports Exerc. 2023;55(1):1-12. 2023. ↩︎